Eton Pharmaceuticals (ETON)
(Real Time Quote from BATS)
$14.46 USD
+0.07 (0.49%)
Updated Aug 5, 2025 03:38 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ETON 14.46 +0.07(0.49%)
Will ETON be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ETON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ETON
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why
ETON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
Other News for ETON
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, ...
BlackRock, Inc. Expands Stake in Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc (ETON) Shares Up 8.03% on Jul 18
Eton Pharma Near Term Catalysts Vanish
Eton Pharmaceuticals management to meet with B. Riley